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doi:10.1016/j.jmii.2011.09.013Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus and group A
Streptoccocus, but no Klebsiella pneumoniae were responsible for bacterial coinfections
during the 2009 and previous influenza pandemics. We hereby report a case with concurrent
bacteremic pneumonia due to an unusual capsular serotype K16 K. pneumoniae and pandemic
(H1N1) 2009 influenza in a patient with nasopharyngeal cancer. Such a coinfection has not
previously been described.
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Pandemic (H1N1) 2009 influenza is an emerging disease that
has rapidly spread worldwide since the first two cases were
recognized in April 2009.1 A study found that 22 (29%) out of
77 fatal cases of severe pandemic (H1N1) 2009 pneumonia
were accompanied by concurrent bacterial pneumonia, andished by Elsevier Taiwan LLC. All rights reserved.
K pneumoniae and H1N1 2009 influenza pneumonia 383Streptococcus pneumoniae was the most common copath-
ogen.2 Here we report a case with concurrent pandemic
(H1N1) 2009 and bacterial pneumonia due to capsular
serotype 16 Klebsiella pneumoniae in a patient with naso-
pharyngeal cancer.Figure 1. Chest radiograph shows bilateral patchy consoli-
dations of the lung.Case report
A 42-year-old man presented with fever, productive cough,
myalgia and progressive dyspnea for three days. Three days
before, he had visited a local hospital due to the sudden
onset of fever and cough. The rapid influenza test of
a nasopharyngeal swab sample was positive for influenza A.
He had been given oseltamivir 75 mg twice daily on
November 23 but there had been no significant improve-
ment in his symptoms.
The patient had a history of nasopharyngeal cancer
diagnosed in 1995 and had been treated by radiotherapy.
He did not recall any history of influenza vaccine. Influenza
A was diagnosed in this patient and four of his companions
during recent travel in China from November 19 to
November 23, 2009. He reported no headache, abdominal
pain, vomiting or diarrhea.
On examination, his body mass index was 17.2 kg/m2
and vital signs were temperature 38.9C, pulse rate
134 beats/min, respiratory rate 26 breaths/min, blood
pressure 104/71 mmHg, and SpO2 76% under ambient air.
Physical examination was unremarkable, except for bilat-
eral coarse crackles on chest auscultation.
Results of laboratory tests were as follows:
 white blood cell count 4480 cells/mm3 (77% neutrophils
and 17% lymphocytes);
 hematocrit, 41%;
 platelet count, 236,000 cells/mm3;
 serum creatinine, 0.8 mg/dL;
 asparatate aminotransferase, 49 U/L (normal <37 U/L);
and
 C-reactive protein, 31.48 mg/dL (normal <0.8 mg/dL).
Arterial blood gas analysis under oxygen therapy via
a non-rebreathing mask revealed the following: pH 7.43,
PCO2 41.2 mmHg, and PO2 134 mmHg. Chest radiography
showed bilateral consolidations (Fig. 1).
The patient was intubated for hypoxemic respiratory
failure and admitted to the intensive care unit. Nasopha-
ryngeal swab specimen for Chlamydia pneumoniae antigen
(bioMerieux, Marcy-I’Etolite, France) was negative. Sero-
logical tests for anti-Mycoplasma pneumoniae IgM (Savyon
Diagnostics Ltd., Ashdod, Israel), Binax NOW S pneumoniae
urinary antigen test (Binax Inc., Portland, ME, USA) and
Legionella urinary antigen test for serogroup 1 (Binax Inc.)
were all negative. The influenza rapid test (QuickVue
Influenza AþB test, Biomerieux, San Diego, CA, USA) for
a nasopharyngeal swab sample remained positive for
influenza A. An in-house real-time reverse-transcriptase
polymerase chain reaction (PCR) can detect pandemic
(H1N1) 2009 influenza virus in a nasopharyngeal swab.
The patient’s poor initial response to oseltamivir meant
that the dose of oseltamivir was doubled to 150 mg twice
daily. Intravenous levofloxacin (750 mg daily) wasempirically prescribed for suspected coexisting bacterial
pneumonia, and was then switched to ceftazidime 2 g every
8 hours. The isolates of K pneumoniae, which grew in both
sputum and blood samples collected on the day of admis-
sion, were only resistant to ampicillin. He was extubated on
the fifth day in hospital and transferred to a general ward
3 days later.
Pulsed-field gel electrophoresis typing of XbaI-digested
genomic DNA materials of two K pneumoniae isolates from
sputum and blood showed that they belonged to the iden-
tical pulsotype.3 The isolates of K pneumoniae were iden-
tified as capsular serotype K16 by PCR-restriction fragment-
length polymorphism and PCR-sequencing analysis of the
capsular polysaccharide synthesis regions, as previously
described.4Discussion
Previous studies showed that S pneumoniae, Haemophilus
influenzae, Staphylococcus aureus and group A Streptoc-
cocus were responsible for most bacterial coinfections
during the 2009 and previous influenza pandemics.2,5,6
Martı´n-Loeches et al reported that bacterial coinfection
developed in 17.5% of 645 patients with pandemic (H1N1)
2009 influenza infection.7 This is the first reported case of
laboratory-confirmed pandemic (H1N1) 2009 influenza virus
and serotype K16 K pneumoniae coinfection causing severe
pneumonia with acute respiratory failure in an immuno-
compromised patient.
Several host conditions, such as chronic lung disease,
immunosuppression and obesity, were identified as risk
factors for severe complications of pandemic (H1N1) 2009.8
In addition, bacterial coinfections were associated with
a higher risk of influenza-related morbidity and
384 C.-C. Lai et al.mortality.2,5,6 Underlying cancer and K pneumoniae
pulmonary coinfection probably contributed to the severity
of pandemic (H1N1) 2009 influenza in this patient.
There is no a single rule that can currently predict
bacterial infections in patients with pandemic (H1N1) 2009,
and therefore it is difficult to determine when to prescribe
broad-spectrum antibiotics for patients with influenza.
This is an important issue, however, in the midst of this
influenza pandemic. If a patient does not receive the
appropriate antibiotic early, the risk of mortality is high.
On the other hand, the overuse of antibiotics creates
selective pressure for antimicrobial-resistant bacteria and
increases the risk of antibiotic-associated diarrhea. In this
case, poor clinical response to oseltamivir may suggest
bacterial coinfection, although such a scenario might be
related to an oseltamivir-resistant influenza strain.8
Therefore, adding antibacterial agents when a patient
fails to respond well to oseltamivir treatment appears to
be warranted.
In conclusion, physicians should consider the possibility
of bacterial coinfections in patients with influenza, espe-
cially when their conditions deteriorate with oseltamivir
treatment. K pneumoniae may be a copathogen in indi-
viduals with pandemic (H1N1) 2009.Conflict of interest statement
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